Daymark Health Raises $11.5M in Seed Funding
Summary
The company intends to use the funds to expand its clinical team, accelerate the development and scale of its platform, and launch new health plan partnerships across the country. The company began operations this year in partnership with a leading payer in the Northeast to provide evidence-based, supportive cancer care to over 2,500 cancer patients. Co-founded by Dr. Justin Bekelman, CEO, Robert Pahlavan and Jonathan Rhodes, Daymark Health partners with health plans to provide in-home and virtual supportive and care to patients with cancer in collaboration with their own oncologists. Daymark’s personalized cancer care program empowers patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home. Alongside Dr. Bekelman, the company has assembled a team of oncology and value-based care leaders including: • Roy Beveridge, former Chief Medical Officer of Humana and U.S. Oncology, who joined Daymark as Executive Board Chair, and • Ezekiel Emanuel, an architect of the Affordable Care Act, who joined as Clinical Advisory Board Chair.